The story of Viagra and its effect on the drug landscape presents a thorny question for potential backers. Initially a blockbuster drug, generics have significantly diminished its market dominance, creating obstacles for companies involved to the original patent holder and subsequent formulas. While certain businesses might gain from niche Viagra-r